Parameters such as gender, BMI before immunotherapy, smoking status, alcohol use, FEV1%, tumor size before immunotherapy, tumor location, tumor type, expression of PD‐L1, CR/PR and clinical stage before immunotherapy remained consistent between the two groups. Here, CD274 is linked to neoplasm.